These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

46 related items for PubMed ID: 3902651

  • 21. [Clinical experience in the treatment of bacterial bronchopneumopathy with cefotaxime].
    Montanari S, Roca A, Pasqua F, Gramiccioni E.
    Clin Ter; 1983 Apr 30; 105(2):119-24. PubMed ID: 6305552
    [No Abstract] [Full Text] [Related]

  • 22. The safety and pharmacokinetics of cefotaxime in the treatment of neonates.
    de Louvois J, Mulhall A, Hurley R.
    Pediatr Pharmacol (New York); 1982 Apr 30; 2(4):275-84. PubMed ID: 6099886
    [Abstract] [Full Text] [Related]

  • 23. [A clinical and laboratory study of China-made cefotaxime].
    Niu WW, Wang QN, Lin YH.
    Zhonghua Nei Ke Za Zhi; 1985 Nov 30; 24(11):641-5, 700. PubMed ID: 3833501
    [No Abstract] [Full Text] [Related]

  • 24. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM, Veldkamp J, Deleers L.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec 30; 21(12):605-10. PubMed ID: 6321367
    [Abstract] [Full Text] [Related]

  • 25. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML, Capra E, Angela GC, Eandi M, Salassa B, Lollini P, Musso E, Pizzo L, Spezia C, Di Nola F.
    Minerva Med; 1983 Sep 22; 74(36):2093-102. PubMed ID: 6312379
    [Abstract] [Full Text] [Related]

  • 26. [Clinical experience of cefotaxime (author's transl)].
    Portier H, Carbon C, Boussougant Y, Destaing F.
    Nouv Presse Med; 1981 Feb 26; 10(8):607-11. PubMed ID: 6259603
    [Abstract] [Full Text] [Related]

  • 27. [Clinical and microbiological study of the use of cefotaxime in a series of predominantly pediatric cases].
    Fabbri A, Marazzi MG, Manno G, Giacchino R.
    Minerva Pediatr; 1983 Mar 15; 35(5):251-6. PubMed ID: 6304483
    [No Abstract] [Full Text] [Related]

  • 28. Effect of frequency of administration on therapeutic efficacy of cefotaxime.
    Parker RH.
    Clin Ther; 1984 Mar 15; 6(4):488-99. PubMed ID: 6088045
    [Abstract] [Full Text] [Related]

  • 29. Cefotaxime sodium (Claforan).
    Med Lett Drugs Ther; 1981 Jul 10; 23(14):61-2. PubMed ID: 6264279
    [No Abstract] [Full Text] [Related]

  • 30. [Clinical considerations on the use of cefotaxime in infectious complications after resuscitation].
    Mangione S, Giannalia ML.
    Minerva Anestesiol; 1983 Nov 10; 49(11):649-52. PubMed ID: 6322053
    [No Abstract] [Full Text] [Related]

  • 31. Clinical efficacy of cefotaxime in two different periods.
    Peralta S, Vitale B, Scarsi C, D'Aiello G, Rotondo G, Delle Vedove G, Rini GB.
    J Chemother; 1989 Jul 10; 1(4 Suppl):648-9. PubMed ID: 16312574
    [No Abstract] [Full Text] [Related]

  • 32. [Claforan].
    Oriol E, Galichet F.
    Soins Gynecol Obstet Pueric Pediatr; 1986 Nov 10; (66):I-II. PubMed ID: 3643652
    [No Abstract] [Full Text] [Related]

  • 33. Workshop on five years of clinical experience with cefotaxime (with special reference to gram-positive infections). February 21 and 22, 1985, West Berlin.
    Infection; 1985 Nov 10; 13 Suppl 1():S1-162. PubMed ID: 3902651
    [No Abstract] [Full Text] [Related]

  • 34. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH, Jones RN, Malledant J, Privitera G.
    J Chemother; 1997 May 10; 9 Suppl 2():19-33. PubMed ID: 9248973
    [Abstract] [Full Text] [Related]

  • 35. [The use of cefotaxime (Claforan) in severe childhood infections].
    Boda D, Gyurkovits K.
    Orv Hetil; 1984 Sep 30; 125(40):2431-2, 2435-6. PubMed ID: 6091016
    [No Abstract] [Full Text] [Related]

  • 36. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
    Karakusis PH, Trenholme GM, Levin S.
    Infection; 1985 Sep 30; 13 Suppl 1():S46-9. PubMed ID: 4055055
    [Abstract] [Full Text] [Related]

  • 37. A controlled study of cefotetan versus cefotaxime in the treatment of acute infections.
    Schmidt G, Lossnitzer K.
    Chemioterapia; 1987 Jun 30; 6(2 Suppl):371-2. PubMed ID: 3334578
    [No Abstract] [Full Text] [Related]

  • 38. Workshop on five years of clinical experience with cefotaxime (with special reference to gram-positive infections). February 21 and 22, 1985, West Berlin.
    Infection; 1985 Jun 30; 13 Suppl 1():S1-162. PubMed ID: 3902651
    [No Abstract] [Full Text] [Related]

  • 39. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH, Jones RN, Malledant J, Privitera G.
    J Chemother; 1997 May 30; 9 Suppl 2():19-33. PubMed ID: 9248973
    [Abstract] [Full Text] [Related]

  • 40. [The use of cefotaxime (Claforan) in severe childhood infections].
    Boda D, Gyurkovits K.
    Orv Hetil; 1984 Sep 30; 125(40):2431-2, 2435-6. PubMed ID: 6091016
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.